Cell-type dependent selectivity of CCK2R signaling (Homo sapiens)
From WikiPathways
Description
This pathway is based on Figure 7 of "Cell-Type Specific CCK2 Receptor Signaling Underlies the Cholecystokinin-Mediated Selective Excitation of Hippocampal Parvalbumin-Positive Fast-Spiking Basket Cells."(See Bibliography).The neuropeptide cholecystokinin (CCK) acts through its receptor CCK2R to achieve largely different functions in different types of cells. CCK, CCK2R, and CB1R have all been known to have substantial effects on anxiety and other mood disorders, and the PV+ interneurons have also been shown to be involved i na variety of cognitive functions. However, In PV+ basket cells and CCK+ basket cells, the CCK2 receptor uses different pathways to exert different effects on the two types of basket cells. For CCK+ basket cells, CCK2 receptors in neighboring pyramidal cells act through the Gq pathway to form endocannabinoids, which, through the cannabinoid receptor type 1 on the CCK+ basket cell, inhibit the release of the neurotransmitter GABA. In contrast, for PV+ basket cells, CCK2 receptors act through the pertussin-toxin sensitive Gi pathway to regulate the intracellular Ca2+ through ryanodine receptors. This pathway ultimately leads to activation of a non-selective cationic conductance to depolarize the PV+ basket cells.
Quality Tags
Ontology Terms
Bibliography
- Lee SY, Földy C, Szabadics J, Soltesz I; ''Cell-type-specific CCK2 receptor signaling underlies the cholecystokinin-mediated selective excitation of hippocampal parvalbumin-positive fast-spiking basket cells.''; J Neurosci, 2011 PubMed Europe PMC Scholia
- Lee SH, Soltesz I; ''Requirement for CB1 but not GABAB receptors in the cholecystokinin mediated inhibition of GABA release from cholecystokinin expressing basket cells.''; J Physiol, 2011 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
2-APB, FFA | Metabolite | 1540 (Chemspider) | |
8-NH2-cADPR | Metabolite | 3081323 (PubChem-compound) | artifically added antagonist of cyclic ADPR |
ADPR | Metabolite | HMDB01178 (HMDB) | adenosine diphosphate ribose |
CB1 | GeneProduct | ENSG00000118432 (Ensembl) | Cannabinoid receptor 1 |
CCK2R | GeneProduct | ENSG00000110148 (Ensembl) | receptor |
CCK | GeneProduct | ENSG00000187094 (Ensembl) | |
DAG lipase | GeneProduct | ENSG00000134780 (Ensembl) | |
DAG | Metabolite | HMDB07015 (HMDB) | |
GABA | Metabolite | 116 (Chemspider) |
|
Gi/0 | GeneProduct | ENSG00000127955 (Ensembl) | |
Gq | GeneProduct | ENSG00000156052 (Ensembl) | |
IP3 receptor | GeneProduct | ENSG00000150995 (Ensembl) | had no significant affect on CCK pathway |
NEM | 4209 (Chemspider) | artifically added inhibitor of Gi/0 | |
PLCB1 | GeneProduct | ENSG00000182621 (Ensembl) | |
Pertussis toxin | IPR003899 (InterPro) |
| |
Ryanodine receptor | GeneProduct | ENSG00000198838 (Ensembl) | channel that allows passage of ER stored Ca2+ |
TRPC1 | GeneProduct | ENSG00000144935 (Ensembl) |
|
U73122 | GeneProduct |
| |
YM022 | GeneProduct | artificially added inhinitor of CCK2 | |
cyclic ADPR | Metabolite | 21403087 (Chemspider) | |
ryanodine | Metabolite | 16736002 (Chemspider) | artificially added inhibitor of ryanodine receptor |
Annotated Interactions
No annotated interactions